Investor Relations
Month Year
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Month Year
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Jul 18, 2023
-
Aug 2, 2022
-
Dec 22, 2021Definitive merger agreements provide the Company with all existing and future assets, future product iterations, and intellectual property rights of the platform, creating a fully integrated product line and streamlining commercialization
-
Nov 11, 2021Solid quarterly results highlighted by record revenue of $30.1 million, pre-tax income of $13.6 million and fully diluted EPS of $0.38
-
Nov 4, 2021Company's validated test available in the UK following implementation of UKHSA CTDA Regulations
-
Sep 27, 2021In addition to hosting a booth to promote its existing diagnostics products at the conference, the Company will also hold a press conference to introduce its upcoming at-home and point-of-care PCR device
-
Sep 13, 2021Company CEO and CFO will also be conducting a presentation that will be available on-demand
-
Sep 8, 2021Peer-reviewed results describe the Company's test being used to confirm the presence of the virus on community waste, including mutated strains